Drug
Diatrizoate Meglumine And Diatrizoate Sodium
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Aspiration | 10 | 51.9 | 53.3 | signal |
| 2 | Nephropathy Toxic | 6 | 30.3 | 30.8 | signal |
| 3 | Thrombotic Microangiopathy | 4 | 23.2 | 23.5 | signal |
| 4 | Product Odour Abnormal | 4 | 21.7 | 21.9 | signal |
| 5 | Pharyngeal Oedema | 6 | 21.6 | 22.0 | signal |
| 6 | Status Epilepticus | 4 | 19.9 | 20.1 | signal |
| 7 | Posterior Reversible Encephalopathy Syndrome | 3 | 17.7 | 17.9 | signal |
| 8 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 17.6 | 18.0 | signal |
| 9 | Incorrect Route Of Drug Administration | 8 | 12.4 | 12.7 | signal |